Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
William Schuyler Jones
Professor of Medicine
Medicine, Cardiology
schuyler.jones@duke.edu
Duke Box 3330, Durham, NC 27710
2400 Pratt Street, 7037, Durham, NC 27705
Research
More About This Person
glance {hide_children: true, active: false, enabled: true}
At a Glance
credentials {hide_children: true, active: false, enabled: true}
Credentials
Education
academic-experience {hide_children: true, active: false, enabled: true}
Academic Experience
Current Appointments & Affiliations
Previous Appointments & Affiliations
Leadership & Clinical Positions
Professional Training and Employment
expertise {hide_children: true, active: false, enabled: true}
Expertise
Keywords
research {hide_children: false, active: true, enabled: true}
Research
Selected Grants
publications {hide_children: true, active: false, enabled: true}
Publications
Selected Publications
artistic-works {hide_children: true, active: false, enabled: false}
Artistic Works / Events
teaching {hide_children: true, active: false, enabled: false}
Teaching
advising-mentoring {hide_children: true, active: false, enabled: false}
Advising & Mentoring
recognition {hide_children: true, active: false, enabled: false}
Recognition
professional-activities {hide_children: true, active: false, enabled: false}
Professional Activities
Manage Profile
Embed Profile Data
Manage Profile
Embed Profile Data
Selected Grants
1/2 IMPRoving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)
Research
Co Investigator ·
Awarded by National Institutes of Health ·
2024 - 2030
V-Intervention
Clinical Trial
Principal Investigator ·
Awarded by Novartis Pharmaceuticals Corporation ·
2025 - 2029
Protect IV
Clinical Trial
Co-Principal Investigator ·
Awarded by Abiomed, Inc. ·
2024 - 2028
Stimulating Access to Research in Residency (StARR) - NHLBI
Inst. Training Prgm or CME
Preceptor ·
Awarded by National Heart, Lung, and Blood Institute ·
2018 - 2028
A TriaL ComparIng the EffectiVEness and ToleraBility of MEdicaTions in Older Adults with STablE Angina and Multiple ChRonic Conditions: The LIVE BETTER Trial
Research
Principal Investigator ·
Awarded by Yale University ·
2022 - 2027
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Clinical Trial
Co-Principal Investigator ·
Awarded by Procyrion, Inc. ·
2023 - 2026
OCEANIC-AFINA
Clinical Trial
Principal Investigator ·
Awarded by Bayer Healthcare Pharmaceuticals Inc ·
2023 - 2026
RECOVER - Subaward from CHOP
Research
Principal Investigator ·
Awarded by Children's Hospital of Philadelphia ·
2021 - 2026
PREvention of CardIovascular and DiabEtic kidNey disease in Type 2 Diabetes
Clinical Trial
Principal Investigator ·
Awarded by Brigham and Women's Hospital ·
2022 - 2026
(PRECIDENTD (PREvention of Cardiovascular and DiabEtic kidNey disease in Type 2 Diabetes)
Research
Principal Investigator ·
Awarded by Brigham and Women's Hospital ·
2022 - 2026
Bayer OCEANIC CEC Stroke SOW
Clinical Trial
Principal Investigator ·
Awarded by Bayer HealthCare Pharmaceuticals, Inc ·
2024 - 2026
VITALITY
Clinical Trial
Principal Investigator ·
Awarded by Bayer HealthCare AG ·
2018 - 2025
Program to Reduce dispArities In the ScrEening for Peripheral Artery Disease among black patients (PRAISE-PAD)
Research
Principal Investigator ·
Awarded by American College of Cardiology Foundation ·
2024 - 2025
COVID-19 Electronic Health Data Initiative
Research
Principal Investigator ·
Awarded by The Task Force for Global Health ·
2024 - 2025
Postdoctoral Training in Cardiovascular Clinical Research
Inst. Training Prgm or CME
Mentor ·
Awarded by National Institutes of Health ·
2003 - 2025
PCORnet CC - Scope 6 - Playbook
Research
Principal Investigator ·
Awarded by Patient-Centered Outcomes Research Institute ·
2024 - 2025
Implementation of a Medication Adherence Instrument among Patients with Symptomatic Peripheral Artery Disease after Peripheral Vascular Intervention
Research
Co-Mentor ·
Awarded by National Institutes of Health ·
2023 - 2025
PCORnet® Infrastructure Capacity Building: Recommendations and Roadmap to Enhance PCORnet Informatics and Capacity for Patient-Centered CER
Research
Principal Investigator ·
Awarded by Patient-Centered Outcomes Research Institute ·
2023 - 2024
Study to Test Risk factor Improvement through Dedicated Education, Engagement, and assessment of patient symptoms in the Cardiac Cath Lab (STRIDE-Cath Lab)
Clinical Trial
Principal Investigator ·
Awarded by Mytonomy Inc. ·
2019 - 2024
Empowering the Participant Voice: Collaborative Infrastructure and Validated Tools for Collecting Participant Feedback to Improve the Clinical Research Enterprise
Research
Co-Principal Investigator ·
Awarded by Rockefeller University ·
2020 - 2024
COVID-19 Electronic Health Data Initiative
Research
Principal Investigator ·
Awarded by The Task Force for Global Health ·
2023 - 2024
The Impact of Care Fragmentation and Healthcare Disparities in Peripheral Artery Disease
Fellowship
Principal Investigator ·
Awarded by American College of Cardiology ·
2023 - 2024
Benefit Risk Tradeoffs Associated with PRO for PAD - Option Period
Research
Co Investigator ·
Awarded by Food and Drug Administration ·
2022 - 2024
Medications and Weight Gain Across the Lifecourse in PCORnet
Research
Principal Investigator ·
Awarded by Harvard Medical School ·
2020 - 2024
EMPACT-MI: A streamlined, multicenter, randomized, parallel group, double-blind placebo-controlled superiority trial to evaluate the effect of EMPAgliflozin on hospitalization for heart failure and mortality in patients with aCuTe Myocardial Infarct
Clinical Trial
Principal Investigator ·
Awarded by Boehringer Ingelheim Corporation ·
2021 - 2024
PAD/CAD Design Studio
Inst. Training Prgm or CME
Principal Investigator ·
Awarded by Novartis Pharmaceuticals Corporation ·
2023 - 2023
ECLIPSE
Clinical Trial
Principal Investigator ·
Awarded by Cardiovascular Systems Inc. ·
2017 - 2023
COVID-19 Electronic Health Data Initiative
Research
Principal Investigator ·
Awarded by The Task Force for Global Health ·
2022 - 2023
Implementation of a Medication Adherence Instrument Among Patients with Symptomatic Peripheral Artery Disease after PVI
Research
Mentor ·
Awarded by American Heart Association ·
2022 - 2023
ADAPTABLE Supplement
Clinical Trial
Investigator ·
Awarded by Patient-Centered Outcomes Research Institute ·
2015 - 2023
ADAPTABLE Manuscripts
Clinical Trial
Principal Investigator ·
Awarded by Bayer HealthCare, LLC ·
2021 - 2022
Sentinel Initiative: CDRN Work Order 1:Sentinel Operations Center "RWE: Establish Routine Querying Capability with a Network of EHR Database"
Research
Principal Investigator ·
Awarded by Harvard Pilgrim Health Care, Inc. ·
2021 - 2022
Benefit Risk Tradeoffs Associated with PRO for PAD
Research
Co Investigator ·
Awarded by Food and Drug Administration ·
2020 - 2022
COVID-19 Electronic Health Data Initiative-Amendment 1
Research
Principal Investigator ·
Awarded by The Task Force for Global Health ·
2020 - 2022
Addressing variability in peripheral arterial disease outcomes using machine learning techniques
Fellowship
Principal Investigator ·
Awarded by National Institutes of Health ·
2020 - 2022
Enhanced X-ray Angiography Analysis and Interpretation Using Deep Learning
Research
Investigator ·
Awarded by Vigilant Medical ·
2019 - 2022
VUMC82202 Amend #2
Research
Principal Investigator ·
Awarded by Vanderbilt University Medical Center ·
2020 - 2021
PACE-CLI (PLX-CLI-03)
Clinical Trial
Principal Investigator ·
Awarded by Pluristem Therapeutics Inc. ·
2018 - 2021
Advancement of PCORnet Infrastructure: Clinical Research Network Project - COVID supplement
Research
Principal Investigator ·
Awarded by Vanderbilt University Medical Center ·
2020 - 2021
Subaward ECU/Mishriky Trial Data Extraction
Research
Principal Investigator ·
Awarded by East Carolina University ·
2020 - 2021
DEFINE-PCI
Clinical Trial
Principal Investigator ·
Awarded by Volcano Corporation ·
2017 - 2021
VOYAGER
Clinical Trial
Principal Investigator ·
Awarded by Bayer Healthcare Pharmaceuticals Inc ·
2015 - 2021
ADAPTABLE
Clinical Trial
Principal Investigator ·
Awarded by Vanderbilt University Medical Center ·
2016 - 2021
A PROSPECTIVE, MULTI-CENTER, SINGLE-ARM INVESTIGATIONAL STUDY IN HIGH OR EXTREME RISK PATIENTS WITH SYMPTOMATIC, SEVERE NATIVE AORTIC STENOSIS
Clinical Trial
Principal Investigator ·
Awarded by Abbott Cardiovascular Systems, Inc. ·
2019 - 2021
CDRN Data Extraction for UNCA-UNC Covid project
Research
Principal Investigator ·
Awarded by University of North Carolina - Asheville ·
2020 - 2020
Influenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated heart failure
Research
Principal Investigator ·
Awarded by Brigham and Women's Hospital ·
2017 - 2020
MSCDRN application
Research
Principal Investigator ·
Awarded by Vanderbilt University Medical Center ·
2018 - 2020
Master Plan for Integration of Innovation Technologies and IC Collaboration Activities
Research
Co Investigator ·
Awarded by Harvard Pilgrim Health Care, Inc. ·
2019 - 2020
Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)
Clinical Trial
Investigator ·
Awarded by Patient-Centered Outcomes Research Institute ·
2015 - 2020
The Duke Renal Impairment Program (DRIP) Initiative
Research
Co Investigator ·
Awarded by American College of Cardiology Foundation ·
2019 - 2020
Splanchnic Nerve Block for Therapy of Acute Heart Failure (Splanchnic HF)
Clinical Trial
Co Investigator ·
Awarded by American Heart Association ·
2017 - 2019
National Patient-Centered Clinical Research Network (PCORnet): Clinical Data Research Networks(CDRNs) Phase II
Research
Principal Investigator ·
Awarded by South Carolina Research Foundation ·
2015 - 2019
Panachen 17582
Clinical Trial
Principal Investigator ·
Awarded by Bayer HealthCare AG ·
2017 - 2019
Pantheon 15128
Clinical Trial
Principal Investigator ·
Awarded by Bayer Pharmaceuticals ·
2017 - 2018
CSI Educational Program Agreement VIII
Conference
Principal Investigator ·
Awarded by Cardiovascular Systems Inc. ·
2017 - 2017
Advancing Medical Device Postmarket Surveillance Infrastructure and Epidemiologic Methodologies through Multi-stakeholder Partnership (U01)
Research
Co Investigator ·
Awarded by Food and Drug Administration ·
2013 - 2017
ENDOMAX CEC and DSMB
Clinical Trial
Principal Investigator ·
Awarded by The Medicines Company ·
2013 - 2017
Variability, Medical Therapy, and Outcomes in Patients with Peripheral Artery Disease Who Undergo Lower Extremity Endovascular Revascularization Procedures
Research
Principal Investigator ·
Awarded by American Heart Association ·
2014 - 2015
TO # 1 - Coordinating Center for Cardiovascular Disease - OPTION YEAR 2
Research
Investigator ·
Awarded by Agency for Healthcare Research and Quality ·
2011 - 2013
PTEN Gene Therapy for Vein Graft Disease
Research
Fellow ·
Awarded by National Institutes of Health ·
2009 - 2012
TO # 1 - Coordinating Center for Cardiovascular Disease
Research
Investigator ·
Awarded by Agency for Healthcare Research and Quality ·
2010 - 2011
